Literature DB >> 22157875

Update on ω-3 polyunsaturated fatty acids in early-stage psychotic disorders.

G Paul Amminger1, Patrick D McGorry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22157875      PMCID： PMC3238074          DOI： 10.1038/npp.2011.187

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  7 in total

1.  Meta-analysis of diffusion tensor imaging studies in schizophrenia.

Authors:  Ian Ellison-Wright; Ed Bullmore
Journal:  Schizophr Res       Date:  2009-01-06       Impact factor: 4.939

2.  Omega-3 fatty acid deficiency: a preventable risk factor for schizophrenia?

Authors:  Robert K McNamara
Journal:  Schizophr Res       Date:  2011-01-26       Impact factor: 4.939

Review 3.  Bioactive lipids in schizophrenia.

Authors:  Gregor E Berger; Stefan Smesny; G Paul Amminger
Journal:  Int Rev Psychiatry       Date:  2006-04

4.  Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline.

Authors:  Ravinder D Reddy; Matcheri S Keshavan; Jeffrey K Yao
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

5.  Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group.

Authors:  J Assies; R Lieverse; P Vreken; R J Wanders; P M Dingemans; D H Linszen
Journal:  Biol Psychiatry       Date:  2001-03-15       Impact factor: 13.382

6.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

Review 7.  Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia.

Authors:  Malcolm Peet
Journal:  Isr J Psychiatry Relat Sci       Date:  2008       Impact factor: 0.481
  7 in total
  18 in total

Review 1.  The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.

Authors:  Gerwyn Morris; Ken Walder; Basant K Puri; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

Review 2.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

3.  Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis.

Authors:  S Smesny; B Milleit; U-C Hipler; C Milleit; M R Schäfer; C M Klier; M Holub; I Holzer; G E Berger; M Otto; I Nenadic; M Berk; P D McGorry; H Sauer; G P Amminger
Journal:  Mol Psychiatry       Date:  2013-03-12       Impact factor: 15.992

4.  The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions.

Authors:  Brandon Abbs; Rashmin M Achalia; Adegoke O Adelufosi; Ahmet Yiğit Aktener; Natalie J Beveridge; Savita G Bhakta; Rachael K Blackman; Emre Bora; M S Byun; Maurice Cabanis; Ricardo Carrion; Christina A Castellani; Tze Jen Chow; M Dmitrzak-Weglarz; Charlotte Gayer-Anderson; Felipe V Gomes; Kristen Haut; Hiroaki Hori; Joshua T Kantrowitz; Taishiro Kishimoto; Frankie H F Lee; Ashleigh Lin; Lena Palaniyappan; Meina Quan; Maria D Rubio; Sonia Ruiz de Azúa; Saddichha Sahoo; Gregory P Strauss; Aleksandra Szczepankiewicz; Andrew D Thompson; Antonella Trotta; Laura M Tully; Hiroyuki Uchida; Eva Velthorst; Jared W Young; Anne O'Shea; Lynn E Delisi
Journal:  Schizophr Res       Date:  2012-08-19       Impact factor: 4.939

Review 5.  Microglial activation and progressive brain changes in schizophrenia.

Authors:  L E Laskaris; M A Di Biase; I Everall; G Chana; A Christopoulos; E Skafidas; V L Cropley; C Pantelis
Journal:  Br J Pharmacol       Date:  2016-01-08       Impact factor: 8.739

Review 6.  The promise of biological markers for treatment response in first-episode psychosis: a systematic review.

Authors:  Guillaume Fond; Marc-Antoine d'Albis; Stéphane Jamain; Ryad Tamouza; Celso Arango; W Wolfgang Fleischhacker; Birte Glenthøj; Markus Leweke; Shôn Lewis; Phillip McGuire; Andreas Meyer-Lindenberg; Iris E Sommer; Inge Winter-van Rossum; Shitij Kapur; René S Kahn; Dan Rujescu; Marion Leboyer
Journal:  Schizophr Bull       Date:  2015-03-10       Impact factor: 9.306

7.  Interventions for prodromal stage of psychosis.

Authors:  Dina Bosnjak Kuharic; Ivana Kekin; Joanne Hew; Martina Rojnic Kuzman; Livia Puljak
Journal:  Cochrane Database Syst Rev       Date:  2019-11-01

8.  Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.

Authors:  G P Amminger; A Mechelli; S Rice; S-W Kim; C M Klier; R K McNamara; M Berk; P D McGorry; M R Schäfer
Journal:  Transl Psychiatry       Date:  2015-01-13       Impact factor: 6.222

Review 9.  Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis.

Authors:  Susan F Sonnenschein; A Grace
Journal:  Expert Opin Ther Targets       Date:  2020-11-26       Impact factor: 6.902

10.  Supplemental N-3 Polyunsaturated Fatty Acids Limit A1-Specific Astrocyte Polarization via Attenuating Mitochondrial Dysfunction in Ischemic Stroke in Mice.

Authors:  Jun Cao; Lijun Dong; Jialiang Luo; Fanning Zeng; Zexuan Hong; Yunzhi Liu; YiBo Zhao; Zhengyuan Xia; Daming Zuo; Li Xu; Tao Tao
Journal:  Oxid Med Cell Longev       Date:  2021-06-09       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.